Detailed explanation of the one-month treatment cost of dasatinib

Dasatinib (Dasatinib) is an important prescription drug that is widely used to treat Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) and other related diseases. Dasatinib provides a new treatment option for both newly diagnosed patients and those who have developed resistance or intolerance to previous treatments such as imatinib. In addition, dasatinib has also shown its therapeutic effect in adult patients with Ph+ acute lymphoblastic leukemia (ALL) and patients who are resistant or intolerant to previous treatments. At the same time, dasatinib can also be used in certain circumstances in pediatric patients 1 year old and older.

In the treatment of chronic phase CMLThe recommended dose of dasatinib is 100 mg daily; while in the treatment of accelerated phase CML, myeloid or lymphoblastic phase CML, and Ph+ ALL, the dose is increased to 140 mg daily. For pediatric patients, dosage needs to be individualized based on body weight.

Currently, the original drug of dasatinib has been launched in China and is available in various specifications, such as 50 mg 60 tablets, 20 mg 60 tablets, etc. According to rough estimates, patients may need to consume 1 to 3 boxes of the drug within one month of receiving dasatinib treatment. The price of each box of medicine is approximately RMB 10,000, so the cost of treatment for a month may be as high as RMB 30,000 or more. Dasatinib has been included in the Category B medical insurance catalog, which means that patients who meet the indications can enjoy a certain degree of reimbursement when purchasing the drug, thereby reducing treatment costs. The specific reimbursement ratio and amount will vary depending on the region and medical insurance policy.

Overseas, the price of dasatinib’s original drug is often higher. The price of each box of medicine may exceed US$10,000, which is equivalent to more than 70,000 RMB. This undoubtedly increases the financial burden on patients. However, it is worth noting that generic versions of dasatinib also exist in overseas markets. These generic drugs have basically the same ingredients as the original drugs, but are relatively affordable. For example, the price of generic drugs produced by pharmaceutical factories in countries such as India and Bangladesh may be only a few hundred yuan per box. Therefore, choosing generic drugs can significantly reduce the patient's treatment costs, and the monthly expenditure may be reduced to several thousand yuan.